Laxatives Market Report 2026

The laxatives market size has grown strongly in recent years. It will grow from $8.39 billion in 2025 to $9.11 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to dietary fiber deficiency, sedentary lifestyles, aging population, hospital constipation management, OTC drug accessibility.

The laxatives market size is expected to see strong growth in the next few years. It will grow to $12.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to preventive digestive health focus, clean-label laxative demand, e-commerce pharmacy growth, IBS prevalence increase, pediatric and geriatric formulation innovation. Major trends in the forecast period include rising demand for OTC digestive solutions, growth of fiber-based and natural laxatives, increased awareness of gut health, expansion of online pharmacy sales, product innovation in gentle formulations.

The rising prevalence of gastric disorders is expected to drive growth in the laxatives market in the coming years. Gastric disorders are medical conditions that affect the stomach’s structure and function, causing symptoms such as pain, indigestion, and inflammation. Their prevalence is increasing due to higher consumption of processed and fast foods, which can disrupt gut health by promoting inflammation and acid imbalance. Laxatives help manage these disorders by promoting bowel movements, relieving constipation, and reducing discomfort caused by digestive blockages. For example, according to Cancer Australia in February 2025, an estimated 2,576 new stomach cancer cases were diagnosed in 2023, with a lifetime diagnosis risk by age 85 of 0.85% overall (1.1% for males and 0.61% for females). Therefore, the rising prevalence of gastric disorders is fueling growth in the laxatives market.

Leading companies in the laxatives market are developing advanced formulations, such as osmotic laxatives, to improve digestive health outcomes while meeting consumer demand for safer, non-habit-forming options. Osmotic laxatives are non-stimulant substances that draw water into the intestines to soften stool and promote bowel movements, commonly containing polyethylene glycol (PEG) or lactulose. For instance, in June 2024, Glenmark Pharmaceuticals, an India-based company, launched LaxaGo, an over-the-counter osmotic laxative. LaxaGo features a PEG 3350 formulation with balanced electrolytes for effective yet gentle relief, a neutral taste for better compliance, and a non-stimulant mechanism that minimizes dependency risks associated with long-term use.

In June 2023, Atlantis Consumer Healthcare Inc., a US-based provider of patient engagement solutions, acquired Avrio Health brands including Senokot, Colace, Betadine, and SlowMag for an undisclosed amount. This acquisition expands Atlantis’s portfolio in digestive wellness and consumer healthcare, enabling the company to provide effective, high-quality over-the-counter products. Avrio Health is a US-based brand known for solutions addressing digestive health, infection prevention, and overall wellness needs.

Major companies operating in the laxatives market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Nestlé Health Science, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Purdue Pharma L.P., Boiron S.A., Ironwood Pharmaceuticals Inc., Ferring Pharmaceuticals, C.B. Fleet Company Inc.

North America was the largest region in the laxatives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laxatives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laxatives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have increased costs in the laxatives market by impacting imports of active ingredients, excipients, flavoring agents, and packaging materials used in tablets, powders, and liquid formulations. Chronic constipation and IBS treatment segments are most affected, particularly in Asia-Pacific and North America where global sourcing of pharmaceutical ingredients is common. Retail pharmacies and hospitals experience margin pressure. However, tariffs are encouraging local production of osmotic and bulk-forming laxatives, improving regional supply resilience.

The laxatives market research report is one of a series of new reports that provides laxatives market statistics, including laxatives industry global market size, regional shares, competitors with a laxatives market share, detailed laxatives market segments, market trends and opportunities, and any further data you may need to thrive in the laxatives industry. This laxatives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Laxatives are substances that help stimulate bowel movements or soften stool to relieve constipation. They are commonly used to manage temporary digestive issues and support regularity. Laxatives work through various mechanisms, including stool softening, increasing bowel movement frequency, or stimulating intestinal muscles.

The main types of laxatives include hypertonic, lubricating, stimulant, volumetric, swelling, and others. Hypertonic laxatives work by drawing water into the intestines through osmosis to promote bowel movements. They are available in forms such as tablets, powders, liquids, suppositories, and gels. These laxatives are used for conditions like chronic constipation, irritable bowel syndrome (IBS), post-surgery recovery, and for weight loss or detox purposes, serving end users including hospitals, clinics, retail pharmacies, and other healthcare settings.

The laxatives market consists of sales of prokinetic agents, herbal and natural laxatives, suppositories, and enemas (local delivery forms). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.